Shay Capital »

Quince Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Quince Therapeutics shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $329k 18k 18.85

More positions owned by Shay Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Take-Two Interactive Software (TTWO)
Ftai Aviation SHS (FTAI)
Purecycle Technologies (PCT)
Corecivic (CXW)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Baidu Spon Adr Rep A (BIDU)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Celsius Hldgs Com New (CELH)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Honeywell International (HON)
Golar Lng SHS (GLNG)
Papa John's Int'l (PZZA)

View all positions for Shay Capital

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Ikarian Capital
Millennium Management
Balyasny Asset Management
Susquehanna International
Squadron Capital Management
Shay Capital
Boothbay Fund Management
Jane Street
Vanguard Capital Management
Cormorant Asset Management
UBS Group
Vanguard Fiduciary Trust
BlackRock
Tower Research Capital

View all funds holding Quince Therapeutics